Roble, Belko & Company, Inc - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 292 filers reported holding NOVOCURE LTD in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.

Quarter-by-quarter ownership
Roble, Belko & Company, Inc ownership history of NOVOCURE LTD
ValueSharesWeighting
Q3 2023$0
-100.0%
200.0%0.00%
Q2 2023$10.0%200.0%0.00%
Q1 2023$10.0%200.0%0.00%
Q4 2022$1
-100.0%
200.0%0.00%
Q3 2022$2,000
+100.0%
200.0%0.00%
Q2 2022$1,000
-50.0%
20
-25.9%
0.00%
Q1 2022$2,000
-66.7%
27
-63.5%
0.00%
-100.0%
Q4 2021$6,000
-33.3%
74
-7.5%
0.00%
-50.0%
Q3 2021$9,000
-59.1%
80
-20.0%
0.00%
-60.0%
Q2 2021$22,000
+100.0%
1000.0%0.01%
+66.7%
Q3 2020$11,000
+83.3%
1000.0%0.00%
+50.0%
Q2 2020$6,000
-14.3%
1000.0%0.00%0.0%
Q1 2020$7,000
-12.5%
1000.0%0.00%0.0%
Q4 2019$8,000
+14.3%
1000.0%0.00%0.0%
Q3 2019$7,000
+16.7%
1000.0%0.00%0.0%
Q2 2019$6,000
+20.0%
1000.0%0.00%0.0%
Q1 2019$5,000
+66.7%
1000.0%0.00%
+100.0%
Q4 2018$3,000
-40.0%
1000.0%0.00%
-50.0%
Q3 2018$5,000
+66.7%
1000.0%0.00%
+100.0%
Q2 2018$3,000
+50.0%
1000.0%0.00%0.0%
Q1 2018$2,0000.0%1000.0%0.00%0.0%
Q4 2017$2,0000.0%1000.0%0.00%0.0%
Q3 2017$2,0001000.00%
Other shareholders
NOVOCURE LTD shareholders Q1 2023
NameSharesValueWeighting ↓
Nordwand Advisors, LLC 1,515,000$111,125,24913.86%
Invus Financial Advisors, LLC 350,884$25,737,34113.70%
HARTLINE INVESTMENT CORP/ 304,482$22,333,7555.08%
GREAT POINT PARTNERS LLC 241,000$17,677,3503.46%
Tri Locum Partners LP 72,400$5,311,0002.15%
Taylor Frigon Capital Management LLC 42,061$3,085,1741.75%
HighVista Strategies LLC 28,007$2,054,3131.22%
HAP Trading, LLC 124,500$10,2941.05%
Private Harbour Investment Management & Counsel, LLC 12,285$901,1050.99%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 32,000$2,344,0000.72%
View complete list of NOVOCURE LTD shareholders